Last Year’s Shortage of Tdap Vaccine for Daily Recovery, Selected as Stockpile Vaccine by KDCA
The Korea Disease Control and Prevention Agency announced on the 2nd that the Tdap vaccine, which prevents diphtheria, tetanus, and pertussis, has been newly selected as a national stockpile vaccine.
The Tdap vaccine experienced supply instability in the second half of last year due to the impact of the return to normal life. The stockpile target quantity for the Tdap vaccine this time is 90,000 doses.
The vaccine stockpiling has been conducted since July 2018 after gathering expert opinions and comprehensively reviewing factors such as import dependency and the availability of alternative vaccines.
Hot Picks Today
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
Since 2019, the agency has prioritized stockpiling intradermal BCG (tuberculosis prevention), MMR (measles, mumps, rubella prevention), and PPSV (pneumococcal prevention) vaccines.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.